Differences in guideline-recommended heart failure medication between Dutch heart failure clinics: an analysis of the CHECK-HF registry.

ABSTRACT: BACKGROUND:Heart failure (HF) is associated with poor prognosis, high morbidity and mortality. The prognosis can be optimised by guideline adherence, which also can be used as a benchmark of quality of care. The purpose of this study was to evaluate differences in use of HF medication between Dutch HF clinics. METHODS:The current analysis was part of a cross-sectional registry of 10,910 chronic HF patients at 34 Dutch outpatient clinics in the period of 2013 until 2016 (CHECK-HF), and focused on the differences in prescription rates between the participating clinics in patients with heart failure with reduced ejection fraction (HFrEF). RESULTS:A total of 8,360 HFrEF patients were included with a mean age of 72.3?±?11.8 years (ranging between 69.1?±?11.9 and 76.6?±?10.0 between the clinics), 63.9% were men (ranging between 54.3 and 78.1%), 27.3% were in New York Heart Association (NYHA) class III/IV (ranging between 8.8 and 62.1%) and the average estimated glomerular filtration rate (eGFR) was 59.6?±?24.6?ml/min (ranging between 45.7?±?23.5 and 97.1?±?16.5). The prescription rates ranged from 58.9-97.4% for beta blockers (p?

SUBMITTER: Linssen GCM 

PROVIDER: S-EPMC7270463 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature